↓ Skip to main content

Cochrane Database of Systematic Reviews

Ketamine for management of acute exacerbations of asthma in children

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs
2 blogs
twitter
16 tweeters
facebook
1 Facebook page
wikipedia
4 Wikipedia pages
googleplus
1 Google+ user
f1000
1 research highlight platform

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
226 Mendeley
Title
Ketamine for management of acute exacerbations of asthma in children
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd009293.pub2
Pubmed ID
Authors

Kana R Jat, Deepak Chawla

Abstract

Asthma is the most common chronic disease in children, and children with asthma frequently visit the paediatric emergency departments with acute exacerbations. Some of these children fail to respond to standard therapy (aerosol beta(2)-agonist with or without aerosol anticholinergic and oral or parenteral corticosteroids) for acute asthma leading to prolonged emergency department stay, hospitalisation, morbidity (e.g. barotrauma, intubation) and death, albeit rarely. Ketamine may relieve bronchospasm and is a potentially promising therapy for children with acute asthma who fail to respond to standard treatment.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Mexico 1 <1%
Denmark 1 <1%
Unknown 222 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 13%
Student > Master 29 13%
Student > Bachelor 22 10%
Other 16 7%
Student > Postgraduate 14 6%
Other 46 20%
Unknown 70 31%
Readers by discipline Count As %
Medicine and Dentistry 85 38%
Nursing and Health Professions 26 12%
Social Sciences 10 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Psychology 6 3%
Other 11 5%
Unknown 81 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2021.
All research outputs
#1,097,203
of 20,991,427 outputs
Outputs from Cochrane database of systematic reviews
#2,634
of 12,064 outputs
Outputs of similar age
#6,086
of 139,991 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 93 outputs
Altmetric has tracked 20,991,427 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,064 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.5. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,991 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.